Genprex, Inc.

Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Their technologies are designed to administer disease-fighting genes, offering new treatment options for large patient populations with limited treatment choices. Genprex's oncology program utilizes its proprietary, non-viral ONCOPREX® Nanoparticle Delivery System, which encapsulates gene-expressing plasmids within lipid nanoparticles. Their lead product candidate, REQORSA™ (quaratusugene ozeplasmid), is being evaluated as a treatment for non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).

Genprex's diabetes gene therapy approach is comprised of a novel infusion process that utilizes an endoscope and an adeno-associated virus (AAV) vector to deliver Pdx1 and MafA genes to the pancreas. In models of Type 1 diabetes, the genes express proteins that transform alpha cells in the pancreas into functional beta-like cells, which can produce insulin. They believe this approach can also rejuvenate and replenish exhausted beta cells in Type 2 diabetes. Genprex is committed to fighting cancer and diabetes through the development of unique and innovative gene therapies.

Genprex, Inc. is a clinical-stage gene therapy company committed to developing life-changing therapies for patients with cancer and diabetes. They focus on providing new treatment options for patients with limited or no existing treatment options by administering disease-fighting genes using their proprietary, non-viral delivery systems. Genprex works with world-class institutions and collaborators to advance their pipeline of gene therapies and provide novel approaches to treat these diseases.

Genprex fosters a culture of innovation, integrity, and excellence. They are passionate about developing life-changing gene therapies and are committed to fighting cancer and diabetes. They value a diverse and multidisciplinary team of professionals with a high level of intellect, experience, and competency, who are driven to deliver results for patients, the company, and stockholders.

Genprex is committed to fostering a diverse, equitable, and inclusive workplace that reflects the diversity of the communities it serves. The company actively seeks to create a culture where all employees feel valued, respected, and empowered to contribute their unique perspectives and talents. By promoting diversity and inclusion at all levels, Genprex aims to attract and retain top talent, cultivate innovation, and drive positive change within the biotechnology industry.